-
10005432-25A prominent member of a class of reactive LO-catalyzed peroxidative decomposition products of unsaturated fatty acids that are formed when diatoms are crushed or eaten.
-
10005432-5A prominent member of a class of reactive LO-catalyzed peroxidative decomposition products of unsaturated fatty acids that are formed when diatoms are crushed or eaten.
-
10005432-50A prominent member of a class of reactive LO-catalyzed peroxidative decomposition products of unsaturated fatty acids that are formed when diatoms are crushed or eaten.
-
10018-1A mechanism-based, irreversible inhibitor of CYP4A2, an enzyme that predominantly synthesizes 20-HETE in the mammalian kidney.
-
10018-10A mechanism-based, irreversible inhibitor of CYP4A2, an enzyme that predominantly synthesizes 20-HETE in the mammalian kidney.
-
10018-5A mechanism-based, irreversible inhibitor of CYP4A2, an enzyme that predominantly synthesizes 20-HETE in the mammalian kidney.
-
18092-1A selective DDR1 inhibitor (IC<sub>50</sub> = 105 nM EC<sub>50</sub> = 87 nM inhibits colorectal cancer cell lines when used in combination with the PI3K/mTOR inhibitor, GSK2126458.
-
18092-10A selective DDR1 inhibitor (IC<sub>50</sub> = 105 nM EC<sub>50</sub> = 87 nM inhibits colorectal cancer cell lines when used in combination with the PI3K/mTOR inhibitor, GSK2126458.
-
18092-5A selective DDR1 inhibitor (IC<sub>50</sub> = 105 nM EC<sub>50</sub> = 87 nM inhibits colorectal cancer cell lines when used in combination with the PI3K/mTOR inhibitor, GSK2126458.
-
82100-10A NO donor with a half-life of 2 minutes at 37°C, pH 7.4 liberates 1.5 moles of NO per mole of parent compound.
-
82100-100A NO donor with a half-life of 2 minutes at 37°C, pH 7.4 liberates 1.5 moles of NO per mole of parent compound.
-
82100-50A NO donor with a half-life of 2 minutes at 37°C, pH 7.4 liberates 1.5 moles of NO per mole of parent compound.